Enterprise Value
50.49M
Cash
34.67M
Avg Qtr Burn
-5.139M
Short % of Float
0.63%
Insider Ownership
0.56%
Institutional Own.
32.85%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CT1812 Details Age-related macular degeneration, Geographic atrophy | Phase 2 Data readout | |
CT1812 Details Alzheimer's disease | Phase 2 Data readout | |
CT1812 Details Dementia | Phase 2 Data readout | |
CT1812 Details Alzheimer's disease | Phase 2 Data readout | |
CT1812 Details Alzheimer's disease | Phase 2 Update |